Final report on the safety assessment of glycyrrhetinic acid, potassium glycyrrhetinate, disodium succinoyl glycyrrhetinate, glyceryl glycyrrhetinate, glycyrrhetinyl stearate, stearyl glycyrrhetinate, glycyrrhizic acid, ammonium glycyrrhizate, dipotassium glycyrrhizate, disodium glycyrrhizate, trisodium glycyrrhizate, methyl glycyrrhizate, and potassium glycyrrhizinate

International Journal of Toxicology

Volumn 26, Issue SUPPL. 2, 2007, Pages 79-112

  Andersen, F Alan ^a  

^a Cosmetic Ingredient Review ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM GLYCYRRHIZATE; DISODIUM GLYCYRRHIZATE; DISODIUM SUCCINOYL GLYCYRRHETINATE; GLYCERYL GLYCYRRHETINATE; GLYCYRRHETINIC ACID DERIVATIVE; GLYCYRRHETINYL STEARATE; GLYCYRRHIZATE DIPOTASSIUM; GLYCYRRHIZIC ACID; METHYL GLYCYRRHIZATE; POTASSIUM GLYCYRRHETINATE; POTASSIUM GLYCYRRHIZINATE; STEARYL GLYCYRRHETINATE; TRISODIUM GLYCYRRHIZATE; UNCLASSIFIED DRUG; COSMETIC; GLYCYRRHETINIC ACID; PLANT EXTRACT;

ANALYTIC METHOD; CANCER INHIBITION; CARCINOGENICITY; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CLINICAL ASSESSMENT; CYTOTOXICITY; DIURESIS; ENZYME ACTIVITY; GENOTOXICITY; HUMAN; LIVER TOXICITY; NEUROTOXICITY; NONHUMAN; PHOTOSENSITIZATION; PHOTOTOXICITY; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; WATER RETENTION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; CONSENSUS; GLYCYRRHIZA; PRODUCT SAFETY; TOXICITY; TOXICITY TESTING;

ANIMALIA; HELICHRYSUM PETIOLARE; HEPATITIS A VIRUS; MESOCRICETUS AURATUS; MUS; ORYCTOLAGUS CUNICULUS; RATTUS; SUIDAE;

ANIMALS; CONSENSUS; CONSUMER PRODUCT SAFETY; COSMETICS; GLYCYRRHETINIC ACID; GLYCYRRHIZA; HUMANS; PLANT EXTRACTS; RISK ASSESSMENT; TOXICITY TESTS;

EID: 34447095946     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701351228     Document Type: Review

References (138)

1. Abe, N., T. Ebina, and N. Ishida. 1982. Interferon induction by glycyrrhizin and glycyrrhretinic acid in mice. Microbiol. Immunol. 56:535-539.
2. Agarwal, R., Z. Y. Wang, and H. Mukhtar. 1991. Inhibition of mouse skin tumor-initiating activity of DBMA by chronic oral feeding of glycyrrhizin in drinking water. Nutr. Cancer. 15:187-193.
3. Akao, T., T. Hayashi, K. Kobashi, M. Kanaoka, H. Kato, M. Kobayashi, S. Takeda, and T. Oyama. 1994. Intestinal bacterial hydrolysis in indispensible to absorption of 18β-glycyrrhetic acid after oral administration of glycyrrhizin in rats. J. Pharm. Pharmacol. 46:135-137.
4. Akao, T. 1997. Hydrolysis of glycyrrhetyl mono-glucuronide to glycyrrhetic acid by glycyrrhetyl mono-glucuronide β-D- glucuronidase of Eubacterium sp. GLH. Biol. Pharm. Bull. 20:1245-1249.
5. 2
6. 2
7. Amagaya, S., E. Sugishita, Y. Ogihara, S. Ogawa, K. Okada, and T. Aizawa. 1984. Comparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities. J. Pharm. Dyn. 7:923-928.
8. Babich, H., E. Borenfreund, and A. Stern. 1993. Comparative cytotoxicities of selected minor dietary non-nutrients with chemopreventive properties. Cancer Lett. 73:127-133.
9. Badam, L. 1997. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (sigma) on Japanese encephalitis virus. J. Commun. Dis. 29:91-99.
10. Böhmer, C., U. Kirschner, and F. Wehner. 2001. Pflügers Arch. Eur. J. Physiol. 442:688-692.
11. Bombardelli, E. 1991. Phytosome®: New cosmetic delivery system. Boll. Chim. Farmaceutico. 130:431-438.
12. Bou-Flores, C., and A. J. Berger. 2001. Gap junctions and inhibitory synapses modulate inspiratory motoneuron synchronization. J. Neurophysiol. 85:1543-1551.
13. Budivari, S., M. J. O'Neil, A. Smith, P. E. Heckelman, eds. 1989. The Merck Index. An encyclopedia of chemicals, drugs, and biologicals, 7th ed. Rahway, NJ: Merck & Co., 244 and 4400.
14. Cantelli-Forti, G., F. Maffei, P. Hrelia, F. Bugamelli, M. Bernardi, P. D'Intino, M. Maranesi, and M. A. Raggi. 1994. Interaction of licorice on glycyrrhizin pharmacokinetics. Environ. Health. Perspect. 102:65-68.
15. Cantelli-Forti, G., M. A. Raggis, F. Bugamelli, F. Maffei, A. Villari, and N. M. Trieff. 1997. Toxicological assessment of licorice: biliary excretion in rats. Pharmacol. Res. 35:463-470.
16. Chitturi, S., and G. C. Farrell. 2001. Drug-induced cholestasis. Semin. Gastrointest. Dis. 12:113-124.
17. 2
18. 2
19. 2
20. Colin-Jones, E. 1957. Glycyrrhetinic acid in dermatology. Practitioner. 178:600-601.
21. Conn, J. W., D. R. Rovner, and E. L. Cohen. 1968. Licorice-induced pseudoaldosteronism. JAMA. 205:80-84.
22. 2
23. 2
24. 2
25. 2
26. Crance, J. M., F. Leveque, H. van Cuyck-Gandre, A. Jouan, and R. Deloince. 1994. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vivo. Antiviral Res. 23:63-76.
27. Dai, J. H., Y. Iwatani, T. Ishida, H. Terunuma, H. Kasai, Y. Iwakula, H. Fujiwara, and M. Ito. 2001. Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology. 103:235-243.
28. Davidson, J. S., and I. M. Baumgarten. 1988. Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J. Pharmacol. Exp. Ther. 264:1104-1107.
29. Davis, E. A., and D. J. Morris. 1991. Medicinal uses of licorice through the millenia: The good and plenty of it. Mol. Cell. Endocrinol. 78:1-6.
30. Donaldson, E. M., and D. A. Duthie. 1956. Clinical trial of glycyrrhetinic ointment. BMJ. 12:1161.
31. European Commission's Scientific Committee on Food (SCF). 2003. Opinion of the scientific committee on food on glycyrrhizinic acid and its ammonium salt. Available at http://europa.eu.int/comm/food/fs/sc/scf/out186_en.pdf.
32. Evans, F. Q. 1958. The rational use of glycyrrhetinic acid in dermatology. Br. J. Clin. Pract. 12:269-274.
33. Finney, R. S. H., G. F. Somers, and J. H. Wilkinson. 1958. The pharmacological properties of glycyrrhetinic acid - a new anti-inflammatory drug. J. Pharm. Pharmacol. 10:687-695.
34. Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
35. 2
36. FDRL. 1971b. Teratologic evaluation of FDA71-1 (ammonium glycyrrhizinate). NTIS Report No. PB221793.
37. 2
38. Fujisawa, K., and B. N. Tandon. 1994. A therapeutic approach to the chronic active liver disease: Summary of a satellite symposium. In: Viral hepatitis and liver disease. K. Nishioka, H. Suzuki, S. Mishiro, et al., eds. Tokyo: Springer. 662-665.
39. 2
40. Gottschalck, T. E., and G. N. McEwen. 2004. International cosmetic ingredient dictionary and handbook, 10th ed. Washington, DC: CTFA.
41. Greaves, M. W. 1990. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet. 336:876.
42. Green, S. 1977. Present and future uses of mutagenicity tests of the safety of food additives. J. Environ. Pathol. Toxicol. 1:49-54.
43. Gujral, M. L., K. Sareen, D. P. Phukan, and M. K. P. Amma. 1961. Antiarthritic activity of glycyrrhizin in adrenalectomized rats. Ind. J. Med. Sci. 15:625-629.
44. Guo, Y., C. Martinez-Williams, K. A. Gilbert, and D. E. Rannels. 1999. Inhibition of gap junction communication in alveolar epithelial cells by 18α-glycyrrhetinic acid. Am. J. Physiol. 276:L1018-L1026.
45. 2
46. 2
47. 2
48. Horigome, H., M. Homma, T. Hirano, and K. Oka. 2001. Glycyrrhetinic acid induced apoptosis in murine splenocytes. Biol. Pharm. Bull. 24:54-58.
49. Hu, C., W. Chen, P. Liao, W. Yu, and Y. Lee. 2001. Synergistic effect of cadmium chloride and acetaldehyde on cytotoxicity and its prevention by quercetin and glycyrrhizin. Mutat. Res. 496:117-127.
50. Ichikawa, T., S. Ishida, Y. Sakiya, Y. Sawada, and M. Hanano. 1986. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats. J. Pharm. Sci. 75:672-675.
51. Iino, S., T. Tango, T. Matsushima, G. Toda, K. Miyake, K. Hino, H. Kumada, K. Yasuda, T. Kuroki, C. Hirayama, and H. Suzuki. 2001. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis. Hepatol. Res. 19:31-40.
52. Imai, T., M. Sakai, H. Ohtake, H. Azuma, and M. Otagiri. 1999. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs. Pharmaceut. Res. 16:80-86.
53. 2
54. Inoue, H., T. Mori, S. Shibata, and Y. Koshihara. 1989. Modulation of glycyrrhetinic acid derivatives of TPA-induced mouse ear edema. Br. J. Pharmacol. 96:204-210.
55. 2
56. Ishida, S., Y. Sakiya, T. Ichikawa, and S. Awazu. 1989. Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats. Chem. Pharm. Bull. 37:2509-2513.
57. Ishida, S., Y. Sakiya, T. Ichikawa, and Z. Taira. 1992. Dose-dependent pharma-cokinetics of glycyrrhizin in rats. Chem. Pharm. Bull. 40:1917-1920.
58. Itami, T., M. Ema, and S. Kanoh. 1985. Effect of disodium glycyrrhizinate on pregnant rats and their offspring. J. Food Hyg. Soc. Jpn. 26:460-464.
59. Jung, G., J. Yang, E. Song, and J. Park. 2001. Stimulation of melanogenesis by glycyrrhizin in B16 melanoma cells. Exp. Mol. Med. 33:131-135.
60. Kelloff, G. J., C. W. Boone, J. A. Crowell, V. E. Steele, R. Lubet, and C. C. Sigman. 1994. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarkers Prevent. 3:85-98.
61. Kilgore, K. S., E. J. Tanhehco, J. L. Park, K. B. Naylor, M. B. Anderson, and B. R. Lucchesi. 1998. Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics. J. Pharmacol. Exp. Ther. 284:427-435.
62. Kiso, Y., M. Tohkin, H. Hikino, M. Hattori, T. Sakamoto, and T. Namba. 1984. Mechanism of antihepatotoxic activity for glycyrrhizin, I effect on free radical generation and lipid peroxidation. Planta Med. 50:298-302.
63. Kitagawa, K., H. Nishino, and A. Iwashima. 1986. Inhibition of the specific binding protein of 12-O-tetradecanoylphorbol-13-acetate to mouse epidermal membrane fractions by glycyrrhetic acid. Oncology. 43:127-130.
64. Kobuke, T., K. Inai, S. Ohe, T. Takemoto, K. Matsuki, H. Nishina, I. B. Huang, and S. Tokouka. 1985. Tumorigenicity study of disodium glycyrrhizinate administered orally to mice. Food Chem. Toxicol. 23:979-983.
65. 2
66. 2
67. Lide, D. R., ed. 1993. CRC handbook of chemistry and physics, 74th ed. Boca Raton, FL: CRC Press.
68. Life Science Research Organization. 1974. Evaluation of the health aspects of licorice, glycyrrhiza, and ammoniated glycyrrhizin as food ingredients. NTIS Report No. PB254529.
69. Lin, G., I. P. Nnane, and T. Cheng. 1999. The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats. Toxicon. 37:1259-1270.
70. 2
71. Liu, H. M., T. Akiyama, N. Sugimoto, and T. Maitani. 2001. Isolation and identification of main constituents in an enzymatically hydrolysed licorice extract sweetener. Food Addit. Contam. 18:281-284.
72. Louis, L. H., and J. W. Conn. 1956. Preparation of glycyrrhizinic acid, the electrolyte-active principle of licorice: its effects upon metabolism and upon pituitary-adrenal function in man. J. Lab. Clin. Med. 47:20-28.
73. Mantovani, A., C. Ricciardi, A. V. Stazi, C. Macri, A. Piccioni, E. Badellino, M. De Vincenzi, S. Caiola, and M. Patriarca. 1988. Teratogenicity study of ammonium glycyrrhizinate in the Sprague-Dawley rat. Food Chem. Toxicol. 26:435-440.
74. 2
75. Molhuysen, J. A., J. Gerbrandy, L. A. de Vries, J. C. de Jong, J. B. Lenstra, K. P. Turner, and J. G. G. Borst. 1950. A liquorice extract with deoxycortone-like action. Lancet. 2:381-386.
76. 2
77. Mori, K., H. Sakai, S. Suzuki, K. Sugal, Y. Akutsu, M. Ishikawa, Y. Seino, N. Ishida, T. Uchida, S. Kariyone, Y. Endo, and A. Miura. 1989. Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C®) in hemophilia patients with HIV infection. Tohoku J. Exp. Med. 158:25-35.
78. Nakamura, T., T. Fujii, and A. Ichihara. 1985. Enzyme leakage due to changes of membrane permeability of primary cultured rat hepatocytes treated with various hepatotoxins and its prevention by glycyrrhizin. Cell Biol. Toxicol. 1:285-295.
79. Nishino, H., K. Kitagawa, and A. Iwashima. 1984. Antitumor-promoting activity of glycyrrhetic acid in mouse skin tumor formation induced by 7, 12-dimethylbenz[a]anthracene plus teleocidin. Carcinogenesis. 5:1529-1530.
80. Nishino, H., K. Yoshioka, A. Iwashima, H. Takizawa, S. Konishi, H. Okamoto, H. Okabe, S. Shibata, H. Fujiki, and T. Sugimura. 1986. Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O- tetradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis. Jpn. J. Cancer Res. 77:33-38.
81. Noda, Y. 1964. Effects of glycyrrhizin and glucuronic acid on hemoglobin and on the activity of certain enzymes. Biochim. Biophys. Acta. 90:159-160.
82. Nokhodchi, A., H. Nazemiyeh, T. Ghafourian, D. Hassan-Zadeh, H. Valizadeh, and L. A. S. Bahary. 2002. The effect of glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations. Farmaco. 57:883-888.
83. Nose, M., M. Ito, K. Kamimura, M. Shimizu, and Y. Ogihara. 1994. A comparison of the antihepatotoxic activity between glycyrrhizin and glycyrrhetinic acid. Planta Med.60:136-139.
84. O'Brian, C. A., N. E. Ward, and V. G. Vogel. 1990. Inhibition of protein kinase C by the 12-O- tetradecanoylphorbol-13-acetate antagonist glycyrrhetic acid. Cancer Lett. 49:9-12.
85. 2 production by activated peritoneal macrophages from rats. Prostaglandins Med. 7:457-463.
86. Okamura, N., T. Maki, H. Miyauchi, M. Shimoe, S. Yokono, H. Yoshitomi, and A. Yagi. 2001. Simultaneous determination of glycyrrhizin, glycyrrhetinic acid and glycyrrhetic acid mono-glucuronide in shakuyaku-kanzo-to incubated with rat feces by semi-micro high-performance liquid chromatography. Biol. Pharm. Bull. 24:1161-1164.
87. Olukoga, A., and D. Donaldson. 2000. Liquorice and its health implications. J. R. Soc. Promot. Health. 120:83-89.
88. Paolini, M., L. Pozzetti, A. Sapone, and G. Cantelli-Forti. 1998. Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases. Life Sci. 62:571-582.
89. Parke, D. V., S. Pollock, and R. Williams. 1963. The fate of tritium-labelled [sic] β-glycyrrhetic acid in the rat. J. Pharm. Pharmacol. 15:500-506.
90. Patrick, L. 1999. Hepatitis C: Epidemiology and review of complimentary/alternative medicine treatments. Altern. Med. Rev. 4:220-238.
91. Ploeger, B., T. Mesinga, A. Sips, C. Deerenberg, J. Meulenbelt, and J. DeJongh. 2001a. A population physiologically based pharmacokinetic/ pharmacodynamic model for the inhibition of 11-β-hydroxysteroid dehydrogenase activity by glycyrrhetic acid. Toxicol. Appl. Pharmacol. 170:46-55.
92. Ploeger, B., T. Mensinga, A. Sips, W. Seinen, J. Meulenbelt, and J. DeJongh. 2001b. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab. Rev. 33:125-147.
93. Pompei, R., O. Flore, M. A. Marccialis, A. Pani, and B. Loddo. 1979. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature. 281:689-690.
94. Quaschning, T., F. Ruschitzka, S. Shaw, T. F. Lüscher. 2001. Aldosterone receptor antagonism normalizes vascular function in licorice-induced hypertension. Hypertension. 37:801-805.
95. 2
96. Rossi, T., R. A. Fano, M. Castelli, M. Malagoli, A. I. Ruberto, G. Baggio, R. Zenaro, M. Migaldi, and G. Barbolini. 1999. Correlation between high intake of glycyrrhizin and myolysis of the papillary muscles: an experimental in vivo study. Pharmacol. Toxicol. 85:221-229.
97. Rossi, T., I. Galatulas, R. Bossa, A. Tampieri, P. Tartoni, G. Baggio, A. I. Ruberto, and M. Castelli. 1995. Influence of glycyrrhizin on the evolution and respiration of Erlich ascite tumour cells. In Vivo. 9:183-186.
98. Rossi, T., G. Vampa, S. Benvenuti, L. A. Pini, I. Galatulas, R. Bossa, M. Castelli, A. I. Ruberto, and G. Baggio. 1994. Glycyrrhizin and 18β-glycyrrhetinic acid: A comparative study of the pharmacological effects induced in the rat after prolonged oral treatment. In Vivo. 8:317-320.
99. Rozental, R., M. Srinivas, and D. C. Spray. 2001. How to close a gap junction channel. Methods Mol. Biol. 154:447-476.
100. Rui, H. 1997. Research and development of cancer chemopreventive agents in China. J. Cell. Biochem. Suppl. 27:7-11.
101. Sakamoto, R., M. Okano, H. Taneka, and K. Ohtsuki. 2001. Inhibitory effect of glycyrrhizin in the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro. Biol. Pharm. Bull. 24:906-911.
102. Sasaki, M., K. Sugimura, M. A. Yoshida, and S. Abe. 1980. Cytogenetic effect of 60 chemicals on cultured human and Chinese hamster cells. La Kromosomo II. 20:574-584.
103. Schiller, P. C., G. D'ippolito, W. Balkan, B. A. Roos, and G. A. Howard. 2001. Gap-junctional communication is required for the maturation process of osteoblastic cells in culture. Bone. 28:362-369.
104. Sekizawa, T., K. Yanagi, and Y. Itoyama. 2001. Glycyrrhizin increases survival of mice with herpes simple encephalitis. Acta Virol. 45:51-54.
105. Sheu, C. W., K. T. Cain, C. J. Rushbrook, T. A. Jorgenson, and W. M. Generoso. 1986. Tests for the mutagenic effects of ammoniated glycyrrhizin, butylated hydroxytoluene, and gum arabic in rodent germ cells. Environ. Mutagen. 8:357-367.
106. Shibayama, Y. 1989. Prevention of hepatotoxic responses to chemicals by glycyrrhizin in rats. Exp. Mol. Pathal. 51:48-55.
107. Sigurjónsdóttir, H. A., L. Franzson, K. Manhem, J. Ragnarsson, G. Sigurdsson, and S. Wallerstedt. 2001. Liquorice-induced rise in blood pressure: a linear dose-response relationship. J. Hum. Hyperten. 15:549-552.
108. Sobotka, T. J., S. L. Spaid, R. E. Brodie, and G. F. Reed. 1981. Neurobehavioral toxicity of ammoniated glycyrrhizin, a licorice component, in rats. Neurobehav. Toxicol. Teratol. 3:37-44.
109. Spinks, E. A., and G. R. Fenwick. 1990. The determination of glycyrrhizin in select UK liquorice products. Food Addit. Contamin. 7:769-778.
110. 2
111. 2
112. Strandberg, T. E., A. L. Järvenpää, H. Vanhanen, and P. M. McKeigue. 2001. Birth outcome in relation to licorice consumption during pregnancy. Am. J. Epidemiol. 153:1085-1088.
113. Tabernero, A., C. Jimënez, A. Velasco, C. Giaume, and J. M. Medina. 2001. The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation. J. Neurochem. 78:890-898.
114. Takasaki, M., T. Konoshima, M. Kosuka, K. Yoneyama, S. Yoshida, H. Okuda, H. Nishino, and A. Iwashima. 1995. Inhibitors of skin-tumor promotion. xiii. Inhibitory effects of euglobals and their related compounds on Epstein-Barr virus activation and on two-stage carcinogenesis of mouse skin tumors. Biol. Pharm. Bull. 18:288-294.
115. Y mice. Biol. Pharm. Bull. 24:484-487.
116. Tanaka, N., Y. Yamamura, T. Santa, H. Kotaki, K. Uchino,Y. Sawada, T. Aikawa, T. Osuga, and T. Iga. 1993. Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis. Biopharm. Drug Dispos. 14:609-614.
117. Tangri, K. K., P. K. Seth, S. S. Parmar, and K. P. Bhargava. 1965. Biochemical study of anti-inflammatory and anti-arthritic properties of glycyrrhetic acid. Biochem. Pharmacol. 14:1277-1281.
118. Teelucksingh, S., A. D. R. Mackie, D. Burt, M. A. McIntyre, L. Brett, and C. R. W. Edwards. 1990. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet. 335:1060-1063.
119. Terasawa, K., M. Bandoh, H. Tosa, and J. Hirate. 1986. Disposition of glycyrrhetic acid and its glycosides in healthy subjects and patients with pseudoaldosteronism. J. Pharmacobio-Dyn. 9:95-100.
120. Touitou, E., R. Segal, S. Pisanty, and I. Milo-Goldzweig. 1988. Glycyrrhizin gel as vehicle for idoxuridine topical preparation: Skin permeation behaviour. Drug Design Deliv. 3:267-272.
121. Trotta, M., E. Peira, F. Debernardi, and M. Gallarate. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int. J. Pharmaceut. 241:319-327.
122. 2
123. 2
124. Utsunomiya, T., M. Kobayashi, M. Ito, D. N. Herndon, R. B. Pollard, and F. Suzuki. 2001. Glycyrrhizin restores the impaired IL-12 production in thermally injured mice. Cytokine. 14:49-55.
125. Utsunomiya, T., M. Kobayashi, R. B. Pollard, and F. Suzuki. 1997. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob. Agents Chemother. 41:551-556.
126. van Gelderen, C. E. M., J. A. Bijlsma, W. van Dokkum, and T. J. F. Savelkoul. 2000. Glycyrrhizic acid: The assessment of a no effect level. Hum. Exp. Toxicol. 19:434-439.
127. Van Rossum, T. G. J., A. G. Vulto, W. C. J. Hop, and S. W. Schalm. 2001. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am. J. Gastroenterol. 96:2432-2437.
128. Wang, Z. Y., R. Agarwal, Z. C. Zhou, D. R. Bickers, and H. Mukhtar. 1991. Inhibition of mutagenicity in Salmonella typhimurium and skin tumor initiating and tumor promoting activities in SENCAR mice by glycyrrhetinic acid: Comparison of 18α- and 18β-stereoisomers. Carcinogenesis. 12:187-192.
129. Wang, Z., M. Kishioka, Y. Kurosaki, T. Nakayama, and T. Kimura. 1995. Gastrointestinal absorption characteristics of glycyrrhizin from glycyrrhiza extract. Biol. Pharm. Bull. 18:1238-1241.
130. Wang, Z., Y. Kurosaki, T. Nakayama, and T. Kimura. 1994. Mechanism of gastrointestinal absorption of glycyrrhizin in rats. Biol. Pharm. Bull. 17:1399-1403.
131. Wang, Z. Y., and D. W. Nixon. 2001. Licorice and cancer. Nutr. Cancer. 39:1-11.
132. Watanabe, M., Y. Uchida, S. Sato, M. Moritani, S. Hamamoto, T. Mishiro, S. Akagi, and Y. Kinoshita. 2001. Report of a case showing a recovery from chronic liver cirrhosis to chronic hepatitis, type C, after glycyrrhizin injection for 2 years and a sustained response by the following interferon therapy. Am. J. Gastroenterol. 96:1947-1949.
133. Whitehouse, M. W., P. G. Dean, and T. G. Halsall. 1967. Uncoupling of oxidative phosphorylation by glycyrrhetic acid, fusidic acid, and some related triterpenoid acids. J. Pharm. Pharmacol. 19:533-544.
134. 2
135. 2
136. Yamamura, Y., J. Kawakami, T. Santa, H. Kotaki, K. Uchino, Y. Sawada, N. Tanaka, and T. Iga. 1992. Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method. J. Pharmaceut. Sciences. 81:1042-1046.
137. Yamamura, Y., T. Santa, H. Kotaki, K. Uchino, Y. Sawada, and T. Iga. 1995. Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability. Biol. Pharm. Bull. 18:337-341.
138. Zhang, Y. H., K. Isobe, F. Nagase, T. Lwin, M. Kato, M. Hamagichi, T. Yokochi, and I. Nakashima. 1993. Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by spleen lymphocytes. Immunology. 79:528-534.